Phase I trial of combined treatment with chl4.18 and R24 monoclonal antibodies and interleukin-2 for...
Phase I trial of combined treatment with chl4.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma
About this item
Full title
Phase I trial of combined treatment with chl4.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma
Author / Creator
Publisher
Berlin: Springer
Journal title
Cancer immunology and immunotherapy, 2006, Vol.55 (7), p.761-774
Language
English
Formats
Publication information
Publisher
Berlin: Springer
Subjects
More information
Alternative Titles
Full title
Phase I trial of combined treatment with chl4.18 and R24 monoclonal antibodies and interleukin-2 for patients with melanoma or sarcoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pascalfrancis_primary_17704641
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pascalfrancis_primary_17704641
Other Identifiers
ISSN
0340-7004